These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31794072)

  • 41. The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions.
    Wezenberg E; Sabbe BG; Hulstijn W; Ruigt GS; Verkes RJ
    J Psychopharmacol; 2007 Aug; 21(6):579-87. PubMed ID: 17092974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
    Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
    Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative tolerability, pharmacodynamics, and pharmacokinetics of a metabolite of a quinolizinone hypnotic and zolpidem in healthy subjects.
    Dingemanse J; Bury M; Hussain Y; van Giersbergen P
    Drug Metab Dispos; 2000 Dec; 28(12):1411-6. PubMed ID: 11095577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
    Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
    Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration.
    Greenblatt DJ; Harmatz JS; Singh NN; Steinberg F; Roth T; Moline ML; Harris SC; Kapil RP
    J Clin Pharmacol; 2014 Mar; 54(3):282-90. PubMed ID: 24203450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of zolpidem on sleep in healthy subjects: a placebo-controlled trial with polysomnographic recordings.
    Blois R; Gaillard JM; Attali P; Coquelin JP
    Clin Ther; 1993; 15(5):797-809. PubMed ID: 8269446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of daytime administration of zolpidem versus triazolam on memory.
    Wesensten NJ; Balkin TJ; Belenky GL
    Eur J Clin Pharmacol; 1995; 48(2):115-22. PubMed ID: 7589024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
    Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
    J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers.
    Fairweather DB; Kerr JS; Hindmarch I
    Eur J Clin Pharmacol; 1992; 43(6):597-601. PubMed ID: 1493840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
    Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
    Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lower doses of sublingual Zolpidem are more effective than oral Zolpidem to anticipate sleep onset in healthy volunteers.
    Valente KD; Hasan R; Tavares SM; Gattaz WF
    Sleep Med; 2013 Jan; 14(1):20-3. PubMed ID: 23218533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia.
    Walsh JK; Deacon S; Dijk DJ; Lundahl J
    Sleep; 2007 May; 30(5):593-602. PubMed ID: 17552374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
    Black J; Pillar G; Hedner J; Polo O; Berkani O; Mangialaio S; Hmissi A; Zammit G; Hajak G
    Sleep Med; 2017 Aug; 36():86-94. PubMed ID: 28735928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic effects of simultaneous administration of single-dose gabapentin 500 mg and zolpidem tartrate 10 mg in healthy volunteers: a randomized, open-label, crossover trial.
    Galitz LA; Jayawardena S; Furey SA
    Drugs R D; 2015 Mar; 15(1):71-7. PubMed ID: 25567214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of a single oral dose of brotizolam.
    Osanai T; Ohkubo T; Yasui N; Kondo T; Kaneko S
    Br J Clin Pharmacol; 2004 Nov; 58(5):476-81. PubMed ID: 15521894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sleep after intranasal progesterone vs. zolpidem and placebo in postmenopausal women - A randomized, double-blind cross over study.
    Schüssler P; Kluge M; Adamczyk M; Beitinger ME; Beitinger P; Bleifuss A; Cordeiro S; Mattern C; Uhr M; Wetter TC; Yassouridis A; Rupprecht R; Friess E; Steiger A
    Psychoneuroendocrinology; 2018 Jun; 92():81-86. PubMed ID: 29649764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem.
    Luurila H; Kivistö KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Apr; 54(2):163-6. PubMed ID: 9626922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo.
    Greenblatt DJ; Legangneux E; Harmatz JS; Weinling E; Freeman J; Rice K; Zammit GK
    J Clin Pharmacol; 2006 Dec; 46(12):1469-80. PubMed ID: 17101746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia.
    Walsh JK; Pollak CP; Scharf MB; Schweitzer PK; Vogel GW
    Clin Neuropharmacol; 2000; 23(1):17-21. PubMed ID: 10682226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.